Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pegasta 6 mg Injection
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$40.23 $28.34
Sidmex Inovia offers bulk export supply of Pegasta 6 mg Injection (Pegfilgrastim 6 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Pegfilgrastim 6 mg
Active Pharmaceutical Ingredient
Pegasta 6 mg Injection
$40.23
$28.34
Sidmex Inovia offers bulk export supply of Pegasta 6 mg Injection (Pegfilgrastim 6 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Pegasta 6 mg injection is a vital prescription medication designed to reduce the risk of infections in patients undergoing cancer treatment. This injectable medication enhances the production of white blood cells, which play a crucial role in bolstering the immune system and defending against infections that may arise during and after chemotherapy. Additionally, Pegasta can be beneficial for individuals recovering from exposure to high levels of radiation, aiding in the restoration of their immune function. It is essential for patients to discuss their medical history and any potential allergies with their healthcare provider before starting this treatment, as there may be specific warnings regarding its use in certain populations. By supporting white blood cell production, Pegasta not only helps patients maintain their health during rigorous treatment regimens but also contributes to improved recovery outcomes. Always consult a healthcare professional for advice tailored to your unique health needs, ensuring safe and effective use of this important medication. Embrace your journey toward recovery with Pegasta, a trusted ally in the fight against infection and the challenges of cancer therapy.
Active Pharmaceutical Ingredient
Uses
• Pegasta 6 mg injection is primarily used to reduce the risk of infections in patients undergoing chemotherapy. Chemotherapy can weaken the immune system, making individuals more susceptible to infections. By administering Pegasta 6 mg injection, healthcare providers help bolster the body's defenses during this vulnerable period. This preventive measure is crucial for maintaining the overall health of patients receiving cancer treatment.
• In addition to infection prevention, Pegasta 6 mg injection plays a role in promoting the recovery of blood cell counts after chemotherapy. Chemotherapy often leads to a decrease in white blood cells, which are essential for fighting infections. By stimulating the production of these cells, Pegasta 6 mg injection aids in restoring the immune system's functionality. This support is vital for patients to continue their cancer treatment without significant interruptions.
• Pegasta 6 mg injection may also be utilized in patients with certain conditions that require enhanced immune response. For individuals with compromised immune systems, this injection can provide additional support during treatments that further lower their defenses. The administration of Pegasta 6 mg injection can help ensure that these patients have a better chance of avoiding complications related to infections. Its role in immune system enhancement is particularly beneficial in delicate clinical scenarios.
Benefits
Pegasta 6 mg works by stimulating your body's immune system to increase the production of white blood cells. The cells that help us fight infections are called white blood cells. You must use this medicine under medical supervision to make it really effective. To help prevent infections, avoid being in crowded places and wash your hands often. Drink plenty of fluids, unless you are told otherwise by your doctor or health care professional.
Side Effects
Pegasta 6 mg Injection adverse effects can vary depending on various factors. Some of the common and severe adverse effects are listed below.
Most Common Side Effects
• Dizziness
• Headache
• Appetite Loss
• Constipation
• Infection in the Urinary and Respiratory Tract
• Hair Loss
• Low Count of Red Blood cells
• Fluctuation in the Blood Pressure
• Diarrhoea
• Dizziness
• Nose Bleeds
• Tingling in Feet and hands
• Chest Pain
• Pain during Urination
Common Side Effects
• Rashes
• Headache
• Nausea
• Bone pain
• Leg pain
How To Use
Pegasta Injection is given through intravenous infusion by your doctor or nurse. Follow the guidelines of the doctor carefully during the treatment. Please do not self-administer this Pegasta 6 mg.
Safety Advice
• Alcohol: It is not known whether it is safe to drink alcohol with Pegasta Injection. Consult your medical doctor for advice.
• Kidney: Pegasta 6 mg Injection is safe to use in patients with kidney disease. No dose change is recommended in patients with kidney impairment, including those with end-stage kidney disease.
• Breastfeeding: Pegasta 6 mg Injection should not be given to lactating women. There is no clinical experience with nursing women.
• Liver: There is only a limited amount of information available on the use of Pegasta 6 mg Injection in patients with liver disease. Consult your medical doctor for advice.
• Pregnancy: Pegasta 6 mg Injection is not recommended during pregnancy or in women who may become pregnant and are not using contraceptives. There are no data available on the use of Pegasta 6 mg Injection in pregnant women. Studies in animals have shown toxicity to the reproductive system. The potential risk to the human embryo or fetus is not known.
• Driving: Pegasta 6 mg has no or negligible effects on the ability to drive or to use machines.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.